Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How I diagnose and treat NPM1-mutated AML
Brunangelo Falini, Lorenzo Brunetti, Maria Paola Martelli
Blood (2020) Vol. 137, Iss. 5, pp. 589-599
Open Access | Times Cited: 59

Showing 26-50 of 59 citing articles:

Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemia
Congxiao Zhang, Runxia Gu, Huijun Wang, et al.
Cancer (2024)
Open Access | Times Cited: 3
The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying NPM1 Mutation
Yi Wang, Andres Quesada, Zhuang Zuo, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 198-198
Open Access | Times Cited: 14
<i>NPM1</i>-Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions
Sanjay S. Patel
Pathobiology (2023) Vol. 91, Iss. 1, pp. 18-29
Open Access | Times Cited: 7
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML
Amanda Lopez, Sanjay S. Patel, Julia T. Geyer, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 17
Integrating holotomography and deep learning for rapid detection of NPM1 mutations in AML
Hyunji Kim, Geon Kim, HeyJung Park, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
A ferroptosis-related gene signature and immune infiltration patterns predict the overall survival in acute myeloid leukemia patients
Yin Zhao, Fang Li, Qinjun Zhou, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 9
Role of Biomarkers in the Management of Acute Myeloid Leukemia
Sara Small, Timothy S. Oh, Leonidas C. Platanias
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14543-14543
Open Access | Times Cited: 9
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia
Fabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9159-9159
Open Access | Times Cited: 12
Mutant NPM1 maintains RASGRP3 protein stability via interaction with MID1 to promote acute myeloid leukemia cell proliferation and autophagy
Youping Wang, Pan Chi, Xia Zhang, et al.
Journal of Leukocyte Biology (2023) Vol. 113, Iss. 5, pp. 504-517
Closed Access | Times Cited: 4
Characteristics and Prognosis of “Acute Promyelocytic Leukemia-like” Nucleophosmin-1-Mutated Acute Myeloid Leukemia in a Retrospective Patient Cohort
Vasiliki Papadopoulou, Giulia Schiavini, G. Stalder, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2282-2282
Open Access | Times Cited: 1
NPM1 is a diagnostic and prognostic biomarker associated with the clinicopathological characteristics of gastric cancer
Changan Guo, Xiaolu Su, Wenjie Wang, et al.
Neoplasma (2022) Vol. 69, Iss. 04, pp. 965-975
Open Access | Times Cited: 7
Could Targeting NPM1c+ Misfolding Be a Promising Strategy for Combating Acute Myeloid Leukemia?
Daniele Florio, Daniela Marasco
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 811-811
Open Access | Times Cited: 1
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax‐based therapy
Guangyang Weng, Jingya Huang, Na An, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 1
AML-Related NPM Mutations Drive p53 Delocalization into the Cytoplasm with Possible Impact on p53-Dependent Stress Response
Aleš Holoubek, Dita Strachotová, Petra Otevřelová, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3266-3266
Open Access | Times Cited: 8
Cytogenetic abnormalities in NPM1-mutated acute myeloid leukemia
Weijia Fu, Aijie Huang, Lili Xu, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 8, pp. 1956-1963
Closed Access | Times Cited: 6
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?
Carlotta Giupponi, Diego Bertoli, Erika Borlenghi, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study
Guangyang Weng, Jingya Huang, Xin He, et al.
Annals of Hematology (2023) Vol. 102, Iss. 12, pp. 3369-3381
Closed Access | Times Cited: 2
A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 in Acute Myeloid Leukemia (AML)
Alessandra Venanzi, Roberta Rossi, Giovanni Martino, et al.
Genes (2021) Vol. 12, Iss. 9, pp. 1426-1426
Open Access | Times Cited: 4
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
Edwin Uriel Suárez, Blanca Boluda, Esperanza Lavilla, et al.
Annals of Hematology (2024)
Closed Access
Acute myeloid leukemia (AML)
Dongbin Xu, Guang Liu, Xia Li, et al.
Elsevier eBooks (2023), pp. 203-267
Closed Access | Times Cited: 1
FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
Daniele Sorcini, Antonella Stella, Antonio Scialdone, et al.
eJHaem (2023) Vol. 4, Iss. 4, pp. 1100-1104
Open Access | Times Cited: 1
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 11, pp. 1563-1576
Closed Access
Influence of Nucleophosmin ( NPM1 ) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration
Claudia Tregnago, Maddalena Benetton, Rhonda E. Ries, et al.
Journal of Clinical Oncology (2024) Vol. 43, Iss. 8, pp. 972-984
Closed Access
Multiplex technologies for the assessment of minimal residual disease and low‐level mutation detection in leukaemia: mass spectrometry versus next‐generation sequencing
Naranie Shanmuganathan, Susan Branford
British Journal of Haematology (2021) Vol. 196, Iss. 1, pp. 19-30
Closed Access | Times Cited: 3
Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid Leukemia
Fengli Li, Na Li, Anyou Wang, et al.
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 1187-1197
Open Access | Times Cited: 2

Scroll to top